Correlation Between Vertex Pharmaceuticals and Galapagos
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and Galapagos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and Galapagos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and Galapagos NV ADR, you can compare the effects of market volatilities on Vertex Pharmaceuticals and Galapagos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of Galapagos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and Galapagos.
Diversification Opportunities for Vertex Pharmaceuticals and Galapagos
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Vertex and Galapagos is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and Galapagos NV ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galapagos NV ADR and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with Galapagos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galapagos NV ADR has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and Galapagos go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and Galapagos
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 1.0 times more return on investment than Galapagos. However, Vertex Pharmaceuticals is 1.0 times less risky than Galapagos. It trades about -0.28 of its potential returns per unit of risk. Galapagos NV ADR is currently generating about -0.59 per unit of risk. If you would invest 42,048 in Vertex Pharmaceuticals on January 30, 2024 and sell it today you would lose (2,300) from holding Vertex Pharmaceuticals or give up 5.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 95.45% |
Values | Daily Returns |
Vertex Pharmaceuticals vs. Galapagos NV ADR
Performance |
Timeline |
Vertex Pharmaceuticals |
Galapagos NV ADR |
Vertex Pharmaceuticals and Galapagos Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vertex Pharmaceuticals and Galapagos
The main advantage of trading using opposite Vertex Pharmaceuticals and Galapagos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, Galapagos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galapagos will offset losses from the drop in Galapagos' long position.Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
Galapagos vs. CytomX Therapeutics | Galapagos vs. Spero Therapeutics | Galapagos vs. Instil Bio | Galapagos vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Transaction History View history of all your transactions and understand their impact on performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |